Blog
54 Articles
Using Ultrasound to Enhance the Effectiveness of Chemotherapy
A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
A New Approach to Immunotherapy for Advanced Pancreatic Cancer
Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.
Using Ice to Prevent Neuropathy
Neuropathy–tingling or numbness in your extremities–is a common side effect of chemotherapy. Learn more about the role of ice in preventing neuropathy.
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
More Research Needed For Neuropathy
Dr. Allyson Ocean discusses the use of glutamine to ease the neuropathy caused by chemotherapy drugs for pancreatic cancer.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease
Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.
Being Persistent Led to my Cancer Diagnosis
Rod Devlin wasn’t getting an answer to his pain but he was persistent until he finally found a doctor that would give him a scan.
Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer
Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.